Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.4.0.3
Debt - Narrative (Details)
1 Months Ended 3 Months Ended
Nov. 05, 2015
USD ($)
Apr. 01, 2015
d
$ / shares
Aug. 30, 2013
USD ($)
conversion_right
shares
Jan. 30, 2013
USD ($)
$ / shares
Jun. 30, 2014
USD ($)
shares
Mar. 31, 2016
USD ($)
institution
$ / shares
Mar. 31, 2015
USD ($)
Dec. 31, 2015
USD ($)
institution
Aug. 20, 2015
USD ($)
Debt Instrument [Line Items]                  
Interest paid           $ 623,000 $ 1,568,000    
Gain (loss) on embedded derivative           100,000      
Credit line capacity           189,484,000      
Goodwill           $ 746,961,000   $ 743,348,000  
Number of financial institutions | institution           9   10  
Bio Reference                  
Debt Instrument [Line Items]                  
Net assets           $ 1,000,000,000      
Goodwill           440,800,000     $ 440,837,000
Intangible assets           $ 518,400,000      
OPKO Health Europe                  
Debt Instrument [Line Items]                  
Weighted average interest rate           3.40%   4.30%  
Minimum | OPKO Health Europe                  
Debt Instrument [Line Items]                  
Variable interest rates           2.70%      
Maximum | OPKO Health Europe                  
Debt Instrument [Line Items]                  
Variable interest rates           6.30%      
Notes                  
Debt Instrument [Line Items]                  
2033 Senior Notes, conversion           $ 0      
Long-term Debt           $ 49,608,000   $ 48,986,000  
Notes | Notes Due February 1, 2033                  
Debt Instrument [Line Items]                  
Debt face amount       $ 175,000,000.0          
Interest rate on notes payable       3.00%   3.00%      
Equivalent redemption price       100.00%          
Conversion Rate           0.1414827      
Conversion price per share | $ / shares   $ 7.07   $ 7.07   $ 7.07      
Convertible debt, threshold percentage of stock price trigger   130.00%   130.00%          
Number of consecutive trading days applicable conversion price   30 days              
Conversion right triggered | conversion_right     1            
2033 Senior Notes, conversion     $ 16,900,000   $ 70,400,000        
Convertible debt, stock issued from conversion | shares     2,396,145            
Interest paid         $ 800,000        
Common stock trigger price | $ / shares   $ 9.19              
Number of trading days | d   20              
Long-term Debt           $ 32,200,000      
Notes | Notes Due February 1, 2033 | Minimum                  
Debt Instrument [Line Items]                  
Number of trading days applicable conversion price       20 days          
Notes | Notes Due February 1, 2033 | Maximum                  
Debt Instrument [Line Items]                  
Number of consecutive trading days applicable conversion price       30 days          
Notes | Notes Due February 1, 2033 | On or after February 1, 2017 and before February 1, 2019                  
Debt Instrument [Line Items]                  
Equivalent redemption price       100.00%          
Line of Credit                  
Debt Instrument [Line Items]                  
Weighted average interest rate           4.60%   4.30%  
Common stock investments, available for sale | Notes | Notes Due February 1, 2033                  
Debt Instrument [Line Items]                  
Convertible debt, stock issued from conversion | shares         10,974,431        
Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Credit line capacity $ 175,000,000.0                
Higher borrowing capacity option $ 275,000,000.0                
Commitment fee percentage 0.25%                
Swingline | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Credit line capacity $ 20,000,000.0                
Letter of Credit | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Credit line capacity $ 20,000,000.0                
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 2.50%                
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 0.35%                
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 0.50%                
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 1.35%                
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 1.50%